Additionally, it addresses the FDA’s communications Using the applicant, the retention of documents that aid the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant could transfer ownership of an SE report to a different applicant and Digital submission in the SE report and amendments